Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001567264-25-000039
Filing Date
2025-05-13
Accepted
2025-05-13 16:01:20
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q intensity-20250331.htm   iXBRL 10-Q 611076
2 EX-31.1 a10q20250331exhibit311.htm EX-31.1 11201
3 EX-31.2 a10q20250331exhibit312.htm EX-31.2 11181
4 EX-32.1 a10q20250331exhibit321.htm EX-32.1 5505
5 EX-32.2 a10q20250331exhibit322.htm EX-32.2 5487
  Complete submission text file 0001567264-25-000039.txt   4367033

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20250331.xsd EX-101.SCH 37334
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT intensity-20250331_cal.xml EX-101.CAL 47597
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT intensity-20250331_def.xml EX-101.DEF 140789
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20250331_lab.xml EX-101.LAB 494707
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20250331_pre.xml EX-101.PRE 338523
72 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20250331_htm.xml XML 441838
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41109 | Film No.: 25939798
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)